Skip to main content

Local AIDS Pharmaceutical Assistance Program

Local AIDS Pharmaceutical Assistance Program

HRSA Service Definition

AIDS Pharmaceutical Assistance services fall into two categories, based on RWHAP Part funding.

1. Local Pharmaceutical Assistance Program (LPAP) is operated by a RWHAP Part A or B recipient or sub-recipient as a supplemental means of providing medication assistance when an ADAP has a restricted formulary, waiting list and/or restricted financial eligibility criteria.

RWHAP Part A or B recipients using the LPAP service category must establish the following:

  • Uniform benefits for all enrolled clients throughout the service area
  • A recordkeeping system for distributed medications
  • An LPAP advisory board
  • A drug formulary approved by the local advisory committee/board
  • A drug distribution system
  • A client enrollment and eligibility determination process that includes screening for ADAP and LPAP eligibility with rescreening at minimum of every six months
  • Coordination with the state’s RWHAP Part B ADAP
    • A statement of need should specify restrictions of the state ADAP and the need for the LPAP
  • Implementation in accordance with requirements of the 340B Drug Pricing Program and the Prime Vendor Program

2. Community Pharmaceutical Assistance Program is provided by a RWHAP Part C or D recipient for the provision of long-term medication assistance to eligible clients in the absence of any other resources. The medication assistance must be greater than 90 days.

RWHAP Part C or D recipients using this service category must establish the following:

  • A financial eligibility criteria and determination process for this specific service category
  • A drug formulary consisting of HIV primary care medications not otherwise available to the client
  • Implementation in accordance with the requirements of the 340B Drug Pricing Program and the Prime Vendor Program

Program Guidance:

For LPAPs: Only RWHAP Part A grant award funds or Part B Base award funds may be used to support an LPAP. ADAP funds may not be used for LPAP support. LPAP funds are not to be used for Emergency Financial Assistance. Emergency Financial Assistance may assist with medications not covered by the LPAP.

For Community Pharmaceutical Assistance: This service category should be used when RWHAP Part C or D funding is expended to routinely refill medications. RWHAP Part C or D recipients should use the Outpatient Ambulatory Health Services or Emergency Financial Assistance service for non-routine, short-term medication assistance.

See: Ryan White HIV/AIDS Program Part A and B National Monitoring Standards

See also: LPAP Policy Clarification Memo

See also: AIDS Drug Assistance Program Treatments and Emergency Financial Assistance

Number of Clients Served, Units Provided, Expenditures, Cost per Client and 3 Year averaged Cost per Client (based on actual expenditures)

Year 2015 2016 2017 2018 2019
Drug Reimbursement Clients 723 319 325 264
Drug Reimbursement Units 3,795 2,111 2,361 1,828
Drug Reimbursement Dollars $1,697,959 $573,286 $505,196 $357,810 $486,328
Allocated Dollars $1,864,218 $516,000 $505,503 $497,810 $486,328
Over/ Underspending $166,259 under $57,286 over $307 under $140,000 over $0

Funding by Part, and info on any other payers

Total Part A Funds (Formula + Supp.) MAI Total Part B Funds (Formula + Supp. NJ) Total Part B Funds (Formula + Supp. PA) Total Part C EIS Funds (State & Local) Total Part D Funds (State & Local) Total Part F Funds
Last Year Allocation $486,328
Current Allocation $483,762

Consumer survey info 2017 n=392

n Used in the last 12 months Needed but did not get (last 12 months)
Local AIDS Pharmaceutical Assistance 139 89.2% 10.8%

Unmet need

For the purposes of this document, need is based on the response of a consumer when asked if there was a service they needed. MMP interviews patients in care and asks consumers if they need a service and if they receive it. Client services unit data identifies needs at the time of initial intake.

2016 MMP Percent with a Need 2018 Client Services Unit Need at Intake
Local AIDS Pharmaceutical Assistance 1.5% 23.1%

Recipient Service Considerations